Is Novartis Pharma Schweizerhalle AG FDA approved?

Novartis Pharma Schweizerhalle AG holds no registered establishment of its own; 6 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.

What drugs does Novartis Pharma Schweizerhalle AG make?

6 products are listed under Novartis Pharma Schweizerhalle AG in the openFDA NDC Directory, most often as powder; liquid. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Novartis Pharma Schweizerhalle AG

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 0
Active NDC listings: 6
Live patents: 0
Countries: 0

Catalogue

Drug listings by form and route

6 active NDC listings: 6 bulk ingredient. By marketing category: BULK INGREDIENT 6.

Dosage form	NDCs
powder	5
liquid	1

Route	NDCs

Labeller name on the listing	NDCs
novartis pharma schweizerhalle ag	6

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
-	INCLISIRAN	liquid	44139-0101BULK INGREDIENT
-	IPTACOPAN	powder	44139-0100BULK INGREDIENT
-	TRAMETINIB DIMETHYL SULFOXIDE	powder	44139-0102BULK INGREDIENT
-	asciminib hydrochloride	powder	44139-0104BULK INGREDIENT
-	eltrombopag olamine	powder	44139-0105BULK INGREDIENT
-	fingolimod hydrochloride	powder	44139-0103BULK INGREDIENT

Enquiry

Common questions

Is Novartis Pharma Schweizerhalle AG FDA approved?: Novartis Pharma Schweizerhalle AG holds no registered establishment of its own; 6 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Novartis Pharma Schweizerhalle AG make?: 6 products are listed under Novartis Pharma Schweizerhalle AG in the openFDA NDC Directory, most often as powder; liquid. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.